Aegate News
Aegate strengthens European management team with senior appointment
London, September 2007 - Aegate, the leading pharmaceutical
authentication company is supporting its rapid European growth with
the appointment of Graham Smith to its management team. Graham
takes on the role of Aegate's Business Development Vice
President.
With over 15 years experience in the pharmaceutical industry,
Graham Smith joins Aegate from AstraZeneca where he was Project
Director for the company's European Supply Chain. Graham has
also worked as Chairman for the European Federation of
Pharmaceutical Industries and Associations (EFPIA) Distribution
Group, the body responsible for recent proposals to harmonise
coding of pharmaceuticals across the EU with unique, mass
serialised numbers using 2D barcode technology.
Graham Smith, Business Development Vice President, said "As
patient safety and drug counterfeiting continues to be a problem
for the global pharmaceutical industry, Aegate's drug
authentication system offers a groundbreaking solution for the
market. I'm excited to be joining the team in leading the
company's success in protecting patients Worldwide."
Backed by the PA Consulting Group, Aegate's patient safety solution supports pharmacists and pharmaceutical manufacturers Worldwide in the authentication of medicines at the point of dispensing. The solution acts as a protective mechanism, securing each end of the supply chain to prevent substandard medicines from reaching patients through identifying potential counterfeits, recalled, expired or even stolen products. Counterfeit and stolen medicines are a growing problem both in developed and developing countries, which are estimated to cost the industry $75 billion by 2010. The Aegate solution is already implemented in Belgium and is currently being introduced in Greece.
Gary Noon, CEO of Aegate, said: "The appointment of Graham
is another step forward for Aegate as we continue to work with
leading pharmaceuticals in ensuring global patient safety standards
can be met. Graham brings with him excellent knowledge and
experience of the pharmaceutical industry and I am delighted to
welcome him to our senior management team."

